Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 5
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.
Mazzotta V, Cozzi-Lepri A, Lanini S, Mondi A, Carletti F, Tavelli A, Gagliardini R, Vita S, Pinnetti C, Aguglia C, Colavita F, Faccendini P, Matusali G, Faraglia F, Beccacece A, Paulicelli J, Girardi E, Nicastri E, Vaia F, Maggi F, Antinori A. Mazzotta V, et al. Among authors: paulicelli j. J Med Virol. 2023 Jun;95(6):e28868. doi: 10.1002/jmv.28868. J Med Virol. 2023. PMID: 37306318 Clinical Trial.
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study).
Camici M, Gagliardini R, Lanini S, Del Duca G, Mondi A, Ottou S, Plazzi MM, De Zottis F, Pinnetti C, Vergori A, Grilli E, Mastrorosa I, Mazzotta V, Paulicelli J, Bellagamba R, Cimini E, Tartaglia E, Notari S, Tempestilli M, Cicalini S, Amendola A, Abbate I, Forbici F, Fabeni L, Girardi E, Vaia F, Maggi F, Antinori A. Camici M, et al. Among authors: paulicelli j. Int J Antimicrob Agents. 2024 Jan;63(1):107049. doi: 10.1016/j.ijantimicag.2023.107049. Epub 2023 Dec 5. Int J Antimicrob Agents. 2024. PMID: 38056572 Free article.
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH.
Gagliardini R, Vergori A, Lorenzini P, Cicalini S, Pinnetti C, Mazzotta V, Mondi A, Mastrorosa I, Camici M, Lanini S, Fusto M, Paulicelli J, Plazzi MM, Marchioni L, Agrati C, Garbuglia AR, Piselli P, Nicastri E, Taglietti F, Palmieri F, D'Offizi G, Girardi E, Vaia F, Antinori A. Gagliardini R, et al. Among authors: paulicelli j. J Clin Med. 2022 Mar 11;11(6):1546. doi: 10.3390/jcm11061546. J Clin Med. 2022. PMID: 35329872 Free PMC article.
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study).
Mastrorosa I, Gagliardini R, Segala FV, Mondi A, Lorenzini P, Cerva C, Taddei E, Bai F, Vergori A, Marcantonio N, Pinnetti C, Cicalini S, Murri R, Mazzotta V, Camici M, Mosti S, Bini T, Maffongelli G, Beccacece A, Milozzi E, Iannetta M, Lamonica S, Fusto M, Plazzi MM, Ottou S, Lichtner M, Fantoni M, Andreoni M, Sarmati L, Cauda R, Girardi E, Nicastri E, D'Arminio Monforte A, Palmieri F, Cingolani A, Vaia F, Antinori A; ESCAPE study group. Mastrorosa I, et al. EClinicalMedicine. 2023 Mar 10;57:101895. doi: 10.1016/j.eclinm.2023.101895. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 36936403 Free PMC article.
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV.
Vergori A, Cozzi Lepri A, Cicalini S, Matusali G, Bordoni V, Lanini S, Meschi S, Iannazzo R, Mazzotta V, Colavita F, Mastrorosa I, Cimini E, Mariotti D, De Pascale L, Marani A, Gallì P, Garbuglia A, Castilletti C, Puro V, Agrati C, Girardi E, Vaia F, Antinori A; HIV-VAC study group. Vergori A, et al. Nat Commun. 2022 Aug 22;13(1):4922. doi: 10.1038/s41467-022-32263-7. Nat Commun. 2022. PMID: 35995780 Free PMC article.
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital.
Mondi A, Gagliardini R, Mazzotta V, Vita S, Carletti F, Pinnetti C, Giancola ML, Specchiarello E, Lanini S, Faraglia F, Minosse C, Paulicelli J, Mariano A, Rozera G, Fontana C, Faccendini P, Maggi F, Girardi E, Vaia F, Nicastri E, Antinori A. Mondi A, et al. Among authors: paulicelli j. J Infect. 2023 Jan;86(1):66-117. doi: 10.1016/j.jinf.2022.11.001. Epub 2022 Nov 5. J Infect. 2023. PMID: 36347428 Free PMC article. No abstract available.
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis.
Mastrorosa I, Cozzi-Lepri A, Colavita F, Lalle E, Mazzotta V, Cimaglia C, Paulicelli J, Matusali G, Fabeni L, Carletti F, Rosati S, Vita S, Giannico G, Piselli P, Biliotti E, Moghazi SA, Mosti S, Girardi E, Nicastri E, Garbuglia AR, Maggi F, Vaia F, Antinori A. Mastrorosa I, et al. Among authors: paulicelli j. J Clin Virol. 2022 Dec;157:105299. doi: 10.1016/j.jcv.2022.105299. Epub 2022 Sep 26. J Clin Virol. 2022. PMID: 36183546 Free PMC article.
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents.
Mazzotta V, Cozzi Lepri A, Colavita F, Rosati S, Lalle E, Cimaglia C, Paulicelli J, Mastrorosa I, Vita S, Fabeni L, Vergori A, Maffongelli G, Carletti F, Lanini S, Caraffa E, Milozzi E, Libertone R, Piselli P, Girardi E, Garbuglia A, Vaia F, Maggi F, Nicastri E, Antinori A; INMI COVID-19 Outpatient Treatment Study Group. Mazzotta V, et al. Among authors: paulicelli j. J Med Virol. 2023 Jan;95(1):e28186. doi: 10.1002/jmv.28186. Epub 2022 Oct 7. J Med Virol. 2023. PMID: 36184918 Free PMC article.
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study.
Mazzotta V, Lepri AC, Matusali G, Cimini E, Piselli P, Aguglia C, Lanini S, Colavita F, Notari S, Oliva A, Meschi S, Casetti R, Mondillo V, Vergori A, Bettini A, Grassi G, Pinnetti C, Lapa D, Tartaglia E, Gallì P, Mondi A, Montagnari G, Gagliardini R, Nicastri E, Lichtner M, Sarmati L, Tamburrini E, Mastroianni C, Stingone C, Siddu A, Barca A, Fontana C, Agrati C, Girardi E, Vaia F, Maggi F, Antinori A; Mpox Vaccine Lazio Study Group. Mazzotta V, et al. EClinicalMedicine. 2024 Jan 12;68:102420. doi: 10.1016/j.eclinm.2023.102420. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38292040 Free PMC article.
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis.
Del Duca G, Tavelli A, Mastrorosa I, Aguglia C, Lanini S, Brita AC, Gagliardini R, Vita S, Vergori A, Paulicelli J, Natalini G, D'Urso A, Piselli P, Gallì P, Mondillo V, Mastroianni C, Tamburrini E, Sarmati L, Stingone C, Lichtner M, Nicastri E, Farinella M, Leserri F, Siddu A, Maggi F, d'Arminio Monforte A, Vairo F, Barca A, Vaia F, Girardi E, Mazzotta V, Antinori A. Del Duca G, et al. Among authors: paulicelli j. Vaccines (Basel). 2023 Nov 27;11(12):1761. doi: 10.3390/vaccines11121761. Vaccines (Basel). 2023. PMID: 38140166 Free PMC article.
11 results